Related Experiment Video

Updated: May 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Is HCMV vaccine an unmet need? The state of art of vaccine development

S Chiurchiu, F I Calo Carducci, F Rocchi

    International Journal of Immunopathology and Pharmacology
    |March 27, 2013
    PubMed

    Insights

    Congenital human cytomegalovirus (HCMV) infection is common and can cause severe infant health issues. This review explores various HCMV vaccine types and strategies for future implementation.

    Area of Science:

    • Virology
    • Immunology
    • Public Health

    Background:

    • Congenital human cytomegalovirus (HCMV) infection affects 0.2-2.5% of live births, making it the most common congenital infection.
    • Approximately 11% of infected newborns exhibit symptoms like organomegaly, thrombocytopenia, and neurological or sensory deficits at birth.
    • A significant percentage (5-25%) of asymptomatic neonates develop long-term sequelae, highlighting the need for effective prevention.

    Discussion:

    • The substantial social and economic burden associated with congenital HCMV infection necessitates the development of preventative measures.
    • Current research has explored diverse vaccine platforms, including live attenuated, subunit, vectored, peptide, DNA, and subviral vaccines.
    • Despite extensive research, no HCMV vaccine is currently available for clinical use.

    Key Insights:

    • Review of various HCMV vaccine candidates and their developmental status.
    • Analysis of potential vaccination strategies, including target populations and implementation approaches.
    • Emphasis on the critical need for a safe and effective HCMV vaccine to mitigate disease burden.

    Outlook:

    • Future research should focus on advancing promising vaccine candidates towards clinical trials.
    • Development of targeted vaccination strategies for pregnant women or newborns is crucial.
    • Successful HCMV vaccine deployment could significantly reduce the incidence and long-term consequences of congenital infection.

    More Related Videos

    Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing12:21

    Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

    Published on: January 7, 2019

    Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector08:10

    Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

    Published on: November 28, 2018

    Related Concept Videos

    Cytomegalovirus Disease01:27

    Cytomegalovirus Disease

    Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    Vaccinations01:51

    Vaccinations

    Overview
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...